Friday, November 27, 2020
Home 2020 October

Monthly Archives: October 2020

Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Recent Headlines.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator -
Hapbee, Biotech Stock Review
Accelerator

Telehealth App Hapbee (HAPB) Goes Public and More.

Editor / Curator -
Hapbee,
All News

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

Editor / Curator -
Dalarada Health, Biotech Stock Review
All News

Dalrada Cervical Cancer Testing Kit Study.

Editor / Curator -
biotech stock review
All News

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’...

Editor / Curator -
Issam Radd
2020 Watch List

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

Editor / Curator -
Biosig
Biotech News

Adding BioSig (BSMG) $2.95 to Watch List.

Editor / Curator -
roland rick perry
Biotech News

Can This Diabetes Drug Make you Smarter?

Editor / Curator -
Stand Down.

Primer: Quantitative Easing, MMT, and Inflation/Deflation, Lyn Alden.

Editor / Curator -
123Page 1 of 3

Latest article

Kevin Harrington Presentation. (Video)

Video Editor / Curator -
The Three Strategies I've Used to Build Businesses. https://youtu.be/aNZAAKxPNlM Shark Tanks’ Kevin...

Holy Cholula! Acquired for $800 Million or Near 10 Times Sales!

All News Editor / Curator -
McCormick to buy hot-sauce maker Cholula for $800 million (CNBC). McCormick said it would buy hot-sauce maker Cholula’s parent...
Biotech Stock Review

Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.

All News Editor / Curator -
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.